NRSN1

gene
On this page

Also known as p24

Summary

NRSN1 (neurensin 1, HGNC:17881) is a protein-coding gene on chromosome 6p22.3, encoding Neurensin-1 (Q8IZ57). May play an important role in neural organelle transport, and in transduction of nerve signals or in nerve growth.

Predicted to be involved in nervous system development. Predicted to be located in cytoplasmic vesicle and growth cone. Predicted to be active in neuron projection; neuronal cell body; and transport vesicle.

Source: NCBI Gene 140767 — RefSeq curated summary.

At a glance

  • GWAS associations: 8
  • Clinical variants (ClinVar): 27 total
  • MANE Select transcript: NM_080723

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17881
Approved symbolNRSN1
Nameneurensin 1
Location6p22.3
Locus typegene with protein product
StatusApproved
Aliasesp24
Ensembl geneENSG00000152954
Ensembl biotypeprotein_coding
OMIM616630
Entrez140767

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 9 protein_coding, 3 protein_coding_CDS_not_defined

ENST00000378475, ENST00000378477, ENST00000378478, ENST00000378491, ENST00000463207, ENST00000468195, ENST00000475830, ENST00000892078, ENST00000892079, ENST00000892080, ENST00000944487, ENST00000944488

RefSeq mRNA: 1 — MANE Select: NM_080723 NM_080723

CCDS: CCDS4549

Canonical transcript exons

ENST00000378491 — 4 exons

ExonStartEnd
ENSE000010853282412812824128200
ENSE000012820512412621524126340
ENSE000014777142414554824147530
ENSE000036509082413431924134516

Expression profiles

Bgee: expression breadth ubiquitous, 156 present calls, max score 96.76.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 6.9235 / max 473.6693, expressed in 162 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
663786.9235162

Top tissues by expression

245 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
dorsolateral prefrontal cortexUBERON:000983496.76gold quality
anterior cingulate cortexUBERON:000983596.61gold quality
Brodmann (1909) area 9UBERON:001354096.19gold quality
prefrontal cortexUBERON:000045196.07gold quality
nucleus accumbensUBERON:000188295.85gold quality
Brodmann (1909) area 46UBERON:000648395.58gold quality
right frontal lobeUBERON:000281095.52gold quality
frontal cortexUBERON:000187095.48gold quality
hypothalamusUBERON:000189895.30gold quality
neocortexUBERON:000195095.09gold quality
amygdalaUBERON:000187694.97gold quality
superior frontal gyrusUBERON:000266194.68gold quality
putamenUBERON:000187494.55gold quality
caudate nucleusUBERON:000187394.33gold quality
middle temporal gyrusUBERON:000277193.84gold quality
cerebral cortexUBERON:000095693.74gold quality
forebrainUBERON:000189093.64gold quality
temporal lobeUBERON:000187193.53gold quality
pituitary glandUBERON:000000793.04gold quality
postcentral gyrusUBERON:000258192.77gold quality
entorhinal cortexUBERON:000272892.22gold quality
parietal lobeUBERON:000187291.94gold quality
ponsUBERON:000098891.82gold quality
brainUBERON:000095591.80gold quality
primary visual cortexUBERON:000243691.79gold quality
Brodmann (1909) area 23UBERON:001355491.75gold quality
adenohypophysisUBERON:000219691.70gold quality
lateral nuclear group of thalamusUBERON:000273691.54gold quality
cortical plateUBERON:000534391.44gold quality
occipital lobeUBERON:000202190.21gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-5061yes1363.40
E-MTAB-3929yes348.13
E-ANND-3yes4.23

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

101 targeting NRSN1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-6740-5P100.0065.64932
HSA-MIR-29A-3P100.0073.111835
HSA-MIR-29B-3P100.0073.181833
HSA-MIR-29C-3P100.0073.151833
HSA-MIR-4283100.0066.422097
HSA-MIR-453199.9969.703181
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-477599.9875.006394
HSA-MIR-56899.9869.862084
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-569699.9872.364487
HSA-MIR-314899.9775.066478
HSA-MIR-570-3P99.9672.414910
HSA-MIR-365899.9673.874379
HSA-MIR-6755-5P99.9565.59464
HSA-MIR-971899.9468.91918
HSA-MIR-806399.9169.763146
HSA-MIR-106A-5P99.9073.942683
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-17-5P99.8973.832665
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-106B-5P99.8874.722795
HSA-MIR-20A-5P99.8874.762769
HSA-MIR-20B-5P99.8874.012621
HSA-MIR-519D-3P99.8873.972607
HSA-MIR-526B-3P99.8874.062587
HSA-MIR-93-5P99.8873.982606

Literature-anchored findings (GeneRIF, showing 5)

  • Cloning, expression and characterization of VMP gene. (PMID:12463420)
  • dilysine retrieval signal-containing p24 proteins, p24alpha(2) and p24delta(1), bind with gamma-secretase complexes and collaborate in attenuating gamma-cleavage of beta-amyloid precursor protein (PMID:20807314)
  • GAL, GAP43 and NRSN1 single nucleotide polymorphisms and related gene-gene interaction networks might be involved in the altered susceptibility to Hirschsprung disease in the Han Chinese population. (PMID:29654647)
  • Neuregulin-1 promotes mitochondrial biogenesis, attenuates mitochondrial dysfunction, and prevents hypoxia/reoxygenation injury in neonatal cardiomyocytes. (PMID:32037595)
  • Developmental dyslexia susceptibility genes DNAAF4, DCDC2, and NRSN1 are associated with brain function in fluently reading adolescents and young adults. (PMID:38610086)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerionrsn1lENSDARG00000056572
danio_rerionrsn1ENSDARG00000111235
mus_musculusNrsn1ENSMUSG00000048978
rattus_norvegicusNrsn1ENSRNOG00000017444

Paralogs (1): NRSN2 (ENSG00000125841)

Protein

Protein identifiers

Neurensin-1Q8IZ57 (reviewed: Q8IZ57)

Alternative names: Neuro-p24, Vesicular membrane protein of 24 kDa

All UniProt accessions (3): Q8IZ57, Q5VTS0, Q5VTS2

UniProt curated annotations — full annotation on UniProt →

Function. May play an important role in neural organelle transport, and in transduction of nerve signals or in nerve growth. May play a role in neurite extension. May play a role in memory consolidation.

Subcellular location. Membrane. Cell projection. Neuron projection.

Tissue specificity. Expressed in brain. Not detectable in other tissues tested.

Similarity. Belongs to the VMP family.

RefSeq proteins (1): NP_542454* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR024883NeurensinFamily

Pfam: PF14927

UniProt features (7 total): transmembrane region 2, sequence variant 2, sequence conflict 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IZ57-F169.200.23

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 80 (showing top): TGGTGCT_MIR29A_MIR29B_MIR29C, DARWICHE_SKIN_TUMOR_PROMOTER_UP, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_UP, DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP, MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP, DAWSON_METHYLATED_IN_LYMPHOMA_TCL1, BRN2_01, AACTTT_UNKNOWN, GOCC_NEURON_PROJECTION, GCM_MAPK10, CREBP1_01, LEE_TARGETS_OF_PTCH1_AND_SUFU_DN, NRSF_01, GOCC_CELL_BODY

GO Biological Process (1): nervous system development (GO:0007399)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (7): membrane (GO:0016020), transport vesicle (GO:0030133), growth cone (GO:0030426), cytoplasmic vesicle (GO:0031410), neuron projection (GO:0043005), neuronal cell body (GO:0043025), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
system development1
binding1
endomembrane system1
cytoplasmic vesicle1
site of polarized growth1
distal axon1
cytoplasm1
intracellular vesicle1
plasma membrane bounded cell projection1
somatodendritic compartment1
cell body1

Protein interactions and networks

STRING

1490 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NRSN1ARHGAP9Q9BRR9630
NRSN1KIAA0319Q5VV43582
NRSN1DCDC2Q9UHG0576
NRSN1CAMK2N1Q7Z7J9541
NRSN1MAPK13O15264488
NRSN1SRRM4A7MD48469
NRSN1KCNH4Q9UQ05436
NRSN1KAAG1Q9UBP8435
NRSN1NGEFQ8N5V2424
NRSN1DNAAF4Q8WXU2424
NRSN1HCRTR1O43613421
NRSN1MAP6D1Q9H9H5400
NRSN1C6orf62Q9GZU0399
NRSN1ACOT13Q9NPJ3392
NRSN1MRS2Q9HD23385

IntAct

24 interactions, top by confidence:

ABTypeScore
FATE1NRSN1psi-mi:“MI:0915”(physical association)0.560
NRSN1TMEM106Cpsi-mi:“MI:0915”(physical association)0.560
NRSN1SPACA1psi-mi:“MI:0915”(physical association)0.560
NRSN1RNF24psi-mi:“MI:0915”(physical association)0.560
FCGR1ANRSN1psi-mi:“MI:0915”(physical association)0.560
NRSN1GPA33psi-mi:“MI:0915”(physical association)0.560
NRSN1LYVE1psi-mi:“MI:0915”(physical association)0.560
NRSN1FAM171A2psi-mi:“MI:0914”(association)0.350
NRSN1IGLC7psi-mi:“MI:0914”(association)0.350
NRSN1TMEM106Cpsi-mi:“MI:0915”(physical association)0.000
NRSN1SPACA1psi-mi:“MI:0915”(physical association)0.000
NRSN1RNF24psi-mi:“MI:0915”(physical association)0.000
NRSN1FCGR1Apsi-mi:“MI:0915”(physical association)0.000
NRSN1GPA33psi-mi:“MI:0915”(physical association)0.000
NRSN1LYVE1psi-mi:“MI:0915”(physical association)0.000

BioGRID (177): NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), EGFL7 (Affinity Capture-MS), RHBDD1 (Affinity Capture-MS), MET (Affinity Capture-MS), B4GALT6 (Affinity Capture-MS), B4GALT5 (Affinity Capture-MS), PTPN23 (Affinity Capture-MS), LGR4 (Affinity Capture-MS), FUT8 (Affinity Capture-MS)

ESM2 similar proteins: A6NCQ9, D2H6Z0, D2H788, D3ZBM4, D4A723, E1C2W7, P97432, P97799, Q13145, Q14596, Q3SWY0, Q3T0Y9, Q3TXX3, Q501R9, Q5F479, Q5R7K2, Q5RC94, Q5RF77, Q5T4F4, Q60943, Q60953, Q68D51, Q68EV7, Q6GND7, Q6INB3, Q6P7B7, Q6P9P8, Q80ZD7, Q80ZD8, Q810L3, Q86WK6, Q8BG47, Q8BGE4, Q8C432, Q8CEF8, Q8HYZ0, Q8IZ57, Q8JZL1, Q8N6D2, Q8N8N0

Diamond homologs: P97799, Q5HZK2, Q8IZ57, Q9GZP1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

27 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance24
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

761 predictions. Top by Δscore:

VariantEffectΔscore
6:24126297:C:Gdonor_gain1.0000
6:24126337:GGGG:Gdonor_gain1.0000
6:24126338:GGGG:Gdonor_gain1.0000
6:24128196:CAAAG:Cdonor_loss1.0000
6:24128197:AAAGG:Adonor_loss1.0000
6:24128198:AAGGT:Adonor_loss1.0000
6:24128199:AGGTA:Adonor_loss1.0000
6:24128200:GGT:Gdonor_loss1.0000
6:24128202:T:Gdonor_loss1.0000
6:24129408:G:GTdonor_gain1.0000
6:24129412:TTTCA:Tdonor_gain1.0000
6:24126338:GGG:Gdonor_gain0.9900
6:24126339:GG:Gdonor_gain0.9900
6:24126339:GGG:Gdonor_gain0.9900
6:24126340:GG:Gdonor_gain0.9900
6:24126341:G:Adonor_loss0.9900
6:24126342:TAG:Tdonor_loss0.9900
6:24128123:AATAG:Aacceptor_loss0.9900
6:24128125:TAGG:Tacceptor_loss0.9900
6:24128126:A:AGacceptor_gain0.9900
6:24128126:AG:Aacceptor_gain0.9900
6:24128127:G:GGacceptor_gain0.9900
6:24128127:GG:Gacceptor_gain0.9900
6:24127096:A:Tdonor_gain0.9800
6:24128127:GGATT:Gacceptor_gain0.9800
6:24128201:G:GGdonor_gain0.9800
6:24129419:G:GGdonor_gain0.9800
6:24134317:AGCTG:Aacceptor_gain0.9800
6:24134318:GCT:Gacceptor_gain0.9800
6:24134318:GCTGG:Gacceptor_gain0.9800

AlphaMissense

1263 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:24134424:T:CF33L0.994
6:24134426:T:AF33L0.994
6:24134426:T:GF33L0.994
6:24134425:T:CF33S0.980
6:24134425:T:GF33C0.977
6:24145728:T:CC124R0.975
6:24145735:G:AG126E0.974
6:24145584:G:AG76R0.972
6:24145584:G:CG76R0.972
6:24145585:G:AG76E0.967
6:24145563:G:CG69R0.965
6:24145714:G:AG119E0.965
6:24145564:G:AG69D0.962
6:24145737:G:CG127R0.960
6:24145713:G:AG119R0.957
6:24145713:G:CG119R0.957
6:24145734:G:AG126R0.955
6:24145734:G:CG126R0.955
6:24145738:G:AG127D0.954
6:24145755:T:CC133R0.953
6:24145685:C:AN109K0.942
6:24145685:C:GN109K0.942
6:24134404:T:AV26D0.941
6:24134401:G:AG25E0.935
6:24145605:G:CG83R0.935
6:24145606:G:AG83D0.930
6:24134407:G:CR27P0.927
6:24134416:T:CL30P0.924
6:24134404:T:CV26A0.920
6:24145716:G:CA120P0.920

dbSNP variants (sampled 300 via entrez): RS1000028123 (6:24137632 T>G), RS1000427877 (6:24124994 G>T), RS1000437205 (6:24135212 G>A), RS1000808923 (6:24128351 GT>G), RS1000846917 (6:24130599 C>A), RS1000973328 (6:24139524 G>A,C), RS1001048561 (6:24136563 C>T), RS1001415934 (6:24129929 G>C,T), RS1001502977 (6:24140450 T>C), RS1001614340 (6:24145982 T>A,C), RS1001640456 (6:24142476 G>A,T), RS1001817627 (6:24128522 C>G,T), RS1001923509 (6:24141453 T>TC), RS1002063541 (6:24146260 G>A,T), RS1002069858 (6:24146729 A>T)

Disease associations

OMIM: gene MIM:616630 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

8 associations (top):

StudyTraitp-value
GCST000905_3Information processing speed4.000000e-06
GCST002127_32Periodontitis (Mean PAL)4.000000e-06
GCST004750_77Squamous cell lung carcinoma3.000000e-06
GCST005023_34Initial pursuit acceleration5.000000e-08
GCST008114_27Type 2 diabetes2.000000e-06
GCST008438_3Alzheimer’s disease in hypertension1.000000e-06
GCST010479_73Coronary artery disease5.000000e-09
GCST90013406_201Liver enzyme levels (alkaline phosphatase)2.000000e-46

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004363information processing speed
EFO:0008434initial pursuit acceleration
EFO:0004533alkaline phosphatase measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
methylmercuric chloridedecreases expression1
ethyl-p-hydroxybenzoatedecreases expression1
S-(1,2-dichlorovinyl)cysteineaffects cotreatment, decreases expression1
beta-methylcholineaffects expression1
CGP 52608affects binding, increases reaction1
jinfukangincreases expression1
Acetaminophenincreases expression1
Arsenicalsincreases methylation1
Benzo(a)pyreneaffects methylation1
Lipopolysaccharidesaffects cotreatment, decreases expression1
Tretinoinincreases expression1
Triclosanincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.